Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up
Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing ...
MMA News1h
Alexander Volkanovski Agrees To Fight Diego Lopes Over Winner Of Ilia Topuria vs. Max Holloway On One Condition
Alexander Volkanovski lost to Ilia Topuria in February 2024, and he would fight Diego Lopes upon his return only on one condition.
The Sports Rush2h
Conor McGregor vs. Jorge Masvidal: Fans Rally for Fight as Michael Chandler Matchup Fades
UFC fans now know who they want to see Conor McGregor fight next with the Michael Chandler fight not looking very promising.
With Conor McGregor off the table (for now), Michael Chandler's UFC title aspirations amplify
Conor McGregor is officially in Michael Chandler’s rear-view now that he’s got another fight booked, but is McGregor ...
US FDA lifts clinical hold on Biomea's diabetes trials after safety review
BMF-219 works by increasing, preserving and reactivating patients’ own healthy insulin-producing cells. Read more at ...
Health on MSN6h
How Often Do You Poop? New Research Shows Bowel Movement Frequency Linked to Overall Health
Researchers identified a “Goldilocks zone” for a healthy gut of pooping one or two times a day. Those in the Goldilocks zone ...
Total Pro Sports6h
Michael Bisping Frustrated With Constant Conor McGregor Conversations – “Every 5 Minutes”
Ex-UFC Champion Michael Bisping expresses frustration over endless discussions of Conor McGregor returning to fight.
‘It makes sense’ – Paddy Pimblett pitched as Conor McGregor’s comeback opponent by retired UFC star
Brendan Schaub has a unique idea for Conor McGregor’s comeback. The former dual-weight champion hasn’t fought since breaking ...
Balanced Outlook with a Hold Rating for Biomea Fusion Amidst Upcoming Milestones and Clinical Developments
Analyst Srikripa Devarakonda of Truist Financial maintained a Hold rating on Biomea Fusion (BMEA – Research Report), with a price target ...
Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials
Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug.
manilatimes10h
Copper Becomes First Custodian to Offer Secure BTC Yield with Core's Integration of BTC Staking
The integration of Core's Dual Staking enables institutional investors to stake BTC and CORE safely within Copper custody accounts ...
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent ...